leukopenia/калијум

Веза се чува у привремену меморију

Чланци Клиничка испитивањаПатенти

Изаберите тип сортирања

Страна 1 од 51 резултати

[Potassium perchlorate as the cause of leukopenia, agranulocytosis and aplastic anemia].

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

Potassium perchlorate only temporarily restores euthyroidism in patients with amiodarone-induced hypothyroidism who continue amiodarone therapy.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

BACKGROUND Amiodarone-induced hypothyroidism (AIH) may occur in patients with or without underlying thyroid disorders. In the latter, restoration of euthyroidism, after amiodarone discontinuation, can be facilitated and accelerated by a short course of potassium perchlorate (KClO4). However, it is

Phase II clinical trial of metronomic chemotherapy with combined irinotecan and tegafur-gimeracil-oteracil potassium in metastatic and recurrent breast cancer.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

BACKGROUND We investigated the efficacy and safety of metronomic chemotherapy with combined irinotecan and tegafur-gimeracil-oteracil potassium (TS-1) in patients with metastatic and recurrent breast cancer (MRBC), and the association between irinotecan metabolizing enzyme

Efficacy and safety of S-1 (tegafur, gimeracil, and oteracil potassium) concurrent with 3-dimensional conformal radiotherapy for newly diagnosed squamous cell carcinoma of the lung in elderly patients.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

OBJECTIVE This study evaluated the efficacy and safety of the combination drug tegafur, gimeracil, and oteracil potassium (S-1) concurrent with 3-dimensional conformal radiotherapy for newly diagnosed squamous cell carcinoma of the lung in elderly patients. METHODS Patients with pathologically or

Ibopamine-induced reversible leukopenia during treatment for congestive heart failure.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

Reversible leukopenia was documented in an 81-year-old woman treated with adjunctive ibopamine 100 mg t.i.d. for chronic congestive heart failure. Her antecedent medical history included stable, mild renal function impairment, mitral regurgitation, atrial fibrillation, recurrent transient ischaemic

Comparison of the antitumor activity of DTIC and 1-p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt on murine transplantable tumors and their hematological toxicity.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

This study describes a comparison of 1-p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt (DM-COOK) and imidazole-4-carboxamide,5-(3,3-dimethyl-1-triazeno) (DTIC) with reference to antitumor activity on different murine tumors and hematological toxicity. DM-COOK appeared comparably or slightly

Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur-0.4 M gimestat-1 M otastat potassium) in advanced gastric cancer patients.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

S-1 is a novel oral anticancer drug, composed of tegafur (FT), gimestat (CDHP) and otastat potassium (Oxo) in a molar ratio of 1:0.4:1, based on the biochemical modulation of 5-fluorouracil (5-FU). CDHP inhibits dihydropyrimidine dehydrogenase (DPD), an enzyme which degrades 5-FU, and maintains

Feasibility study of adjuvant chemotherapy with S-1 (TS-1; tegafur, gimeracil, oteracil potassium) for gastric cancer.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

BACKGROUND We conducted a feasibility study using S-1, a novel oral derivative of 5-fluorouracil, as postoperative adjuvant chemotherapy for curatively resected gastric cancer patients. METHODS Adjuvant chemotherapy consisted of eight courses (4-week administration and 2-week withdrawal) of S-1, at

[Phase I study of S-1. S-1 Study Group].

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

We have conducted Phase I study of a novel oral antitumor agent of fluorinated pyrimidines, S-1, in which tegafur (FT) is combined with two classes of modulator, 5-chloro-2,4-dihydroxypyridine (CDHP) and potassium oxonate (Oxo) at a molar ratio of FT:CDHP:Oxo = 1:0.4:1 as a multi-center study with

Adverse event profiles of 5-fluorouracil and capecitabine: data mining of the public version of the FDA Adverse Event Reporting System, AERS, and reproducibility of clinical observations.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

OBJECTIVE The safety profiles of oral fluoropyrimidines were compared with 5-fluorouracil (5-FU) using adverse event reports (AERs) submitted to the Adverse Event Reporting System, AERS, of the US Food and Drug Administration (FDA). METHODS After a revision of arbitrary drug names and the deletion

THE BLOOD IN HOG CHOLERA.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

1. Prolonged and systematic examination of blood from swine with hog cholera has failed to reveal any formed element that could be identified with the etiological virus. Culture has likewise been unsuccessful. 2. The quantitative blood changes in hog cholera consist in a slowly progressive anemia,

[Provision for adverse effect of S-1 containing chemotherapy in patients with advanced digestive cancer--combination with superfine dispersed lentinan].

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

OBJECTIVE Recently, in drug therapy for patients with advanced digestive cancer, S-1 (tegafur x gimeracil x oteracil potassium) alone or S-1 combined with other chemotherapeutic agents (S-1+alpha) is prescribed. However, many patients are often forced to give up long-term S-1 treatment owing to high

Phase I/II study of irinotecan (CPT-11) and S-1 in the treatment of advanced gastric cancer.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

A phase I/II study to determine the recommended dose for combination therapy with CPT-11 (irinotecan hydrochloride) and S-1 (tegafur, gimestat and otastat potassium) for advanced or recurrent gastric cancer, and to assess the safety and efficacy of this therapy. In the phase I portion of the study,

[Clinical features of severe new influenza A (H1N1) in pregnant women].

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

OBJECTIVE To investigate the clinical characteristics of severe influenza A (H1N1) in pregnant women. METHODS Sixteen patients with severe pneumonia caused by influenza A (H1N1) were included in this study from November 26 to December 20, 2009. RESULTS All of the sixteen patients were young women,

Hematological and biochemical profiles and histopathological evaluation of experimental intoxication by sodium fluoroacetate in cats.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

Sodium fluoroacetate (SFAC) is a potent rodenticide, largely used for rodent and domestic pest control. The toxic effects of SFAC are caused by fluoroacetate, a toxic metabolite, whose toxic action blocks the Krebs cycle and also induces the accumulation of citrate in the body, which is a serum

Претходна
1
2
3
4
Следећи

Придружите се нашој
facebook страници

Herbal & Natural Medicine

Најкомплетнија база лековитог биља подржана науком

Ради на 55 језика
Биљни лекови потпомогнути науком
Препознавање биљака по слици
Интерактивна ГПС мапа - означите биље на локацији (ускоро)
Читајте научне публикације повезане са вашом претрагом
Претражите лековито биље по њиховим ефектима
Организујте своја интересовања и будите у току са истраживањем вести, клиничким испитивањима и патентима

Упишите симптом или болест и прочитајте о биљкама које би могле да помогну, укуцајте неку биљку и погледајте болести и симптоме против којих се користи.
* Све информације се заснивају на објављеним научним истраживањима